J. Kobashigawa, Beverly Hills, CA, United States of America
Cedars-Sinai Heart InstitutePoster Author Of 28 e-Posters
758 - Is the VAS Quality of Life Assessment Tool Sensitive to Both Male and Female MCSD Patients?
Presentation Number
758
Session Name
PO-1-NHSAH - Poster Session 1: Nursing, Health Sciences, Allied Health
Date
Wed, Apr 11, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- F. Arabia, Los Angeles, CA, United States of America
- H. Barone, Los Angeles, CA, United States of America
- B. Coleman, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- J. Hajj, Los Angeles, CA, United States of America
- N. Huie, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- M. Lindsay, Los Angeles, CA, United States of America
- E. Passano, Los Angeles, CA, United States of America
- C. Runyan, Los Angeles, CA, United States of America
766 - Histologic and Molecular Microscope Determinants of Graft Survival in the INTERHEART Study: The Greater Importance of T Cell-mediated Rejection vs. Antibody-mediated Rejection in Graft Loss
Presentation Number
766
Presenter
Session Name
PO-1-PATH - Poster Session 1: Pathology
Date
Wed, Apr 11, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- A. Aliabadi, Vienna, Austria
- P. Bruneval, Paris, France
- M. Cadeiras, Los Angeles, CA, United States of America
- M. Crespo-Leiro, A Coruña, Spain
- M. Deng, Los Angeles, CA, United States of America
- E. DePasquale, Los Angeles, CA, United States of America
- J. Goekler, Vienna, Austria
- P. Halloran, Edmonton, AB, Canada
- D. Kim, Edmonton, AB, Canada
- J. Kobashigawa, Beverly Hills, CA, United States of America
- A. Loupy, Paris, France
- P. MacDonald, Darlinghurst, Australia
- L. Potena, Bologna, Italy
- J. Reeve, Edmonton, AB, Canada
- A. Zuckermann, Vienna, Austria
767 - Validating the INTERHEART Classifiers for Molecular Diagnosis of Rejection in 558 New Endomyocardial Biopsies
Presentation Number
767
Presenter
Session Name
PO-1-PATH - Poster Session 1: Pathology
Date
Wed, Apr 11, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- A. Aliabadi, Vienna, Austria
- P. Bruneval, Paris, France
- M. Cadeiras, Los Angeles, CA, United States of America
- M. Crespo-Leiro, A Coruña, Spain
- M. Deng, Los Angeles, CA, United States of America
- E. DePasquale, Los Angeles, CA, United States of America
- J. Goekler, Vienna, Austria
- P. Halloran, Edmonton, AB, Canada
- D. Kim, Edmonton, AB, Canada
- J. Kobashigawa, Beverly Hills, CA, United States of America
- A. Loupy, Paris, France
- P. MacDonald, Darlinghurst, Australia
- L. Potena, Bologna, Italy
- J. Reeve, Edmonton, AB, Canada
- A. Zuckermann, Vienna, Austria
834 - The Use of Cardiac MRI to Detect Myocardial Fibrosis and Development of Restrictive Cardiac Physiology After HTx
Presentation Number
834
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Berman, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- D. Leong, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- B. Tamarappoo, Los Angeles, CA, United States of America
- L. Thomson, Los Angeles, CA, United States of America
845 - Gene Expression Profiling for Cardiac Transplant Recipients: Results from the Outcomes AlloMap® Registry
Presentation Number
845
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- P. Berman, Tampa, FL, United States of America
- G. Ewald, St. Louis, MO, United States of America
- S. Hall, Dallas, TX, United States of America
- A. Kao, Kansas City, MO, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- J. Sninsky, Brisbane, CA, United States of America
- N. Sulemanjee, Milwaukee, WI, United States of America
- T. Wolf-Doty, Brisbane, CA, United States of America
- J. Yee, Brisbane, CA, United States of America
876 - Does Commuting Time to the Transplant Center Affect Compliance with Visits and Outcome after HTx in a big Metropolitan Area?
Presentation Number
876
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- T. Kao, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Patel, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
877 - Use of “Needle in the Arm” Donors for Urgent Status Recipients in Heart Transplantation
Presentation Number
877
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- M. Curry, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- S. Mersola, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
893 - Does a Redo Heart Transplant Decrease the Chance for Primary Graft Dysfunction?
Presentation Number
893
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- B. Kearney, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
895 - Does Occupation Affect Outcome Following Heart Transplantation
Presentation Number
895
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- T. Kao, Los Angeles, CA, United States of America
- B. Kearney, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Sanford, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
901 - Older Kidney Donors in Dual Heart-kidney Transplantation: How Do They Stack Up?
Presentation Number
901
Session Name
PO-2-HTX - Poster Session 2: Heart Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- J. Baker, Los Angeles, CA, United States of America
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
907 - Epstein-Barr Virus Mismatch (Donor+/Recipient-): Is Cancer the Only Risk?
Presentation Number
907
Session Name
PO-2-ID - Poster Session 2: Infectious Diseases
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Hamilton, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
909 - Multi-Drug Resistant Infection after Heart Transplantation: How Serious is This?
Presentation Number
909
Session Name
PO-2-ID - Poster Session 2: Infectious Diseases
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Shen, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
- R. Zabner, Los Angeles, CA, United States of America
- P. Zakowski, Los Angeles, CA, United States of America
944 - Length of Time on Left Ventricular Assist Device Prior to Heart Transplant: Does it Affect Outcome?
Presentation Number
944
Session Name
PO-2-MCS - Poster Session 2: Mechanical Circulatory Support
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- A. Nikolova, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
/thumbnails/0.png)
954 - Utility of Hypercoagulable Work-Up in Predicting Post-Operative Complications in Total Artificial Heart (TAH) Implant Patients
Presentation Number
954
Session Name
PO-2-MCS - Poster Session 2: Mechanical Circulatory Support
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- F. Arabia, Los Angeles, CA, United States of America
- B. Coleman, Los Angeles, CA, United States of America
- D. Collier, San Francisco, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- L. Lam, Los Angeles, CA, United States of America
- R. Lee, San Francisco, CA, United States of America
- D. Mochizuki, San Francisco, CA, United States of America
- J. Moriguchi, Los Angeles, CA, United States of America
- M. Pollack, San Francisco, CA, United States of America
1060 - Does Ex Vivo Perfusion Lead to More or Less Intimal Thickening in the First-year Post-Heart Transplantation?
Presentation Number
1060
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- B. Azarbal, Los Angeles, CA, United States of America
- R. Cheng, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- T. Khayal, Andover, MA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- T. Sato, Los Angeles, CA, United States of America
1061 - Combined Heart and Kidney Transplantation - Is There a Protective Effect Against Cardiac Allograft Vasculopathy Using Intravascular Ultrasound?
Presentation Number
1061
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- B. Azarbal, Los Angeles, CA, United States of America
- R. Cheng, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- T. Kao, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- T. Sato, Los Angeles, CA, United States of America
1087 - Liver Fibrosis Predicts Survival After Heart Transplant
Presentation Number
1087
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Nguyen, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- T. Tran, Los Angeles, CA, United States of America
1088 - Does a History of Malignancy Prior to Heart-transplant Increase Post-transplant Risk?
Presentation Number
1088
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- T. Davis, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hsu, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Norland, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
1120 - Characterization of Vasoplegia Immediately After Heart Transplantation
Presentation Number
1120
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- F. DeLeon, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
1122 - Jehovah Witness Patients: Should We Liberalize Criteria for Heart Transplantation?
Presentation Number
1122
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- N. Musto, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- R. Sharoff, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
1131 - Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
Presentation Number
1131
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- N. Lam, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- D. Luthringer, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1132 - The Clinical Impact of Early vs Late HLA Donor-Specific Antibody Development After Heart Transplantation
Presentation Number
1132
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- J. Davis, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Hamilton, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Trento, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1133 - Is the Luminex 1:8 Dilution Truly the Poor Man’s C1q for Patients Awaiting Heart Transplantation?
Presentation Number
1133
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- R. Bleiker, Los Angeles, CA, United States of America
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1134 - Is First-year DSA After Heart Transplantation Truly a Biomarker for the Development of Cardiac Allograft Vasculopathy?
Presentation Number
1134
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- M. Curry, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Olive, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1135 - Does ATG Induction Prevent Donor-specific Antibodies After Heart Transplantation?
Presentation Number
1135
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Norland, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- D. Ramzy, Los angeles, CA, United States of America
1136 - Novel Methods for Assessing Response to Desensitization
Presentation Number
1136
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- M. Hamilton, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- K. Norland, Los Angeles, CA, United States of America
- M. Pando, Temple, TX, United States of America
- J. Patel, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1137 - Pre-Transplant Memory/Antibody Status Predicts Rejection Risk in the First-Year After Heart Transplantation
Presentation Number
1137
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- D. Chang, Los Angeles, CA, United States of America
- J. Chung, Los Angeles, CA, United States of America
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- A. Hage, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. MacKinnon, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
- A. Velleca, Los Angeles, CA, United States of America
- X. Zhang, Los Angeles, CA, United States of America
1138 - In Sensitized Pre-Transplant Patients, Does IVIG after Heart Transplant Have any Benefit?
Presentation Number
1138
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors
- L. Czer, Los Angeles, CA, United States of America
- S. Dimbil, Beverly Hills, CA, United States of America
- F. Esmailian, Los Angeles, CA, United States of America
- D. Geft, Los Angeles, CA, United States of America
- B. Kearney, Los Angeles, CA, United States of America
- M. Kittleson, Los Angeles, CA, United States of America
- J. Kobashigawa, Beverly Hills, CA, United States of America
- E. Kransdorf, Los Angeles, CA, United States of America
- R. Levine, Los Angeles, CA, United States of America
- J. Patel, Los Angeles, CA, United States of America
Poster Author Of 2 e-Posters
Plenary
HTX - Diagnostics/Patient Management
43 - Molecular Diagnosis of Rejection Phenotypes in 889 Heart Transplant Biopsies: The INTERHEART Study
Presentation Number
43
Presenter
Co-Authors
- A. Aliabadi, Vienna, Austria
- P. Bruneval, Paris, France
- M. Cadeiras, Los Angeles, CA, United States of America
- M. Crespo-Leiro, A Coruña, Spain
- M. Deng, Los Angeles, CA, United States of America
- E. DePasquale, Los Angeles, CA, United States of America
- J. Goekler, Vienna, Austria
- P. Halloran, Edmonton, AB, Canada
- D. Kim, Edmonton, AB, Canada
- J. Kobashigawa, Beverly Hills, CA, United States of America
- A. Loupy, Paris, France
- P. MacDonald, Darlinghurst, Australia
- L. Potena, Bologna, Italy
- J. Reeve, Edmonton, AB, Canada
- A. Zuckermann, Vienna, Austria
Oral
HTX - Acute Rejection
178 - By Molecular Analysis, Many ISHLT Histologic Rejection Diagnoses Are Associated With Molecular Injury, Not Molecular Rejection
Presentation Number
178
Presenter
Co-Authors
- A. Aliabadi, Vienna, Austria
- P. Bruneval, Paris, France
- M. Cadeiras, Los Angeles, CA, United States of America
- M. Crespo-Leiro, A Coruña, Spain
- M. Deng, Los Angeles, CA, United States of America
- E. DePasquale, Los Angeles, CA, United States of America
- J. Goekler, Vienna, Austria
- P. Halloran, Edmonton, AB, Canada
- D. Kim, Edmonton, AB, Canada
- J. Kobashigawa, Beverly Hills, CA, United States of America
- A. Loupy, Paris, France
- P. MacDonald, Darlinghurst, Australia
- L. Potena, Bologna, Italy
- J. Reeve, Edmonton, AB, Canada
- A. Zuckermann, Vienna, Austria
Questions about ePosters? Contact CTI Meeting Technologies Technical Support at ishlt@support.ctimeetingtech.com or 217-398-1792.
Questions about the "ISHLT 38th Annual Meeting and Scientific Sessions"? Contact communications@ishlt.org.
CTI Meeting Technologies© All Rights Reserved.